Results 211 to 220 of about 98,994 (359)
ABSTRACT Introduction Preferentially expressed antigen in melanoma (PRAME) immunohistochemistry helps distinguish non‐acral melanocytic lesions, but few studies have addressed its value in acral lesions. We aimed to identify an optimal PRAME cut‐off score to differentiate acral melanoma (AM) from acral melanocytic nevi (AMN).
Kritsada Phatcharamaneepakorn +4 more
wiley +1 more source
Cutaneous Melanoma in the Context of Aging. [PDF]
Neagu M, Constantin C, Zurac S.
europepmc +1 more source
Prognostic Significance of Nuclear ING3 Expression in Human Cutaneous Melanoma [PDF]
Yemin Wang +3 more
openalex +1 more source
Cytology‐First Diagnostic Workflow for Melanoma of Unknown Primary With Molecular Profiling
Cytology‑first diagnostic workflow for melanoma of unknown primary. Fine‑needle aspiration of an enlarged lymph node enables rapid cytologic evaluation and immunocytochemical confirmation of melanocytic lineage (SOX10). This early cytologic diagnosis facilitates timely surgical excision and comprehensive genomic profiling, supporting integrated ...
Hong Yu +3 more
wiley +1 more source
Hypothyroidism as Prognostic Factor in Cutaneous Melanoma: A 1553-Patient Single-Center Study. [PDF]
Klose J +8 more
europepmc +1 more source
Impact of Ulceration in Stages I to III Cutaneous Melanoma As Staged by the American Joint Committee on Cancer Staging System: An Analysis of the German Central Malignant Melanoma Registry [PDF]
Thomas Eigentler +3 more
openalex +1 more source
Association Between Blood Transfusion and Survival Outcomes in Metastatic Cutaneous Melanoma Treated with Nivolumab. [PDF]
Coskun A +8 more
europepmc +1 more source

